Changes in Beta-Cell Function during Dapagliflozin Therapy in Combination with Exenatide in Type 2 Diabetes Patients (T2D)

被引：0
|
作者：
Defronzo, Ralph A.
Baskoy, Gozde
Triplitt, Curtis L.
Cersosimo, Eugenio
Solis-Herrera, Carolina
Adams, John M., II
Hansis-Diarte, Andrea A.
Gastaldelli, Amalia
Chavez, Alberto
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1550-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1550-P
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Combination therapy with linagliptin and empagliflozin improves alpha- and beta cell function in patients with type 2 diabetes
    Forst, T. A.
    Andersen, G.
    Falk, A.
    Moerschel, L. Plum
    Fischer, A.
    Kapitza, C.
    Heise, T.
    DIABETOLOGIA, 2016, 59 : S373 - S373
  • [42] Beta-cell response to metformin-glibenclamide combination tablets (Glucovance®) in patients with type 2 diabetes
    Bruce, S.
    Park, J-S
    Fiedorek, F. T.
    Howlett, H. C. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (07) : 783 - 790
  • [43] Assessment of beta-cell responsiveness by IVGTT in patients with type 2 diabetes: An exploratory trial in patients who have substituted exenatide for insulin
    Davis, Stephen
    Johns, Don
    Northrup, Justin
    Maggs, David
    Bhole, Deepak
    Xu, Hangtao
    Brodows, Robert
    DIABETES, 2007, 56 : A138 - A138
  • [44] Effect of Short-Term Intensive Insulin Therapy on Beta-Cell Function in Type 2 Diabetes
    Retnakaran, Ravi
    Yakubovich, Natalia
    Qi, Ying
    Opsteen, Christine
    Zinman, Bernard
    DIABETES, 2009, 58 : A131 - A132
  • [45] Myokine Regulation of Beta-Cell Mass and Function: Impact of Type 2 Diabetes
    Ciaraldi, Theodore P.
    Gomez, Daniela
    Baxi, Sunita
    Mudaliar, Sunder R.
    Henry, Robert R.
    DIABETES, 2013, 62 : A506 - A506
  • [46] Interventions to Preserve Beta-Cell Function in the Management and Prevention of Type 2 Diabetes
    Kathleen A. Page
    Tamar Reisman
    Current Diabetes Reports, 2013, 13 : 252 - 260
  • [47] Biomarkers for Assessing Beta-Cell Function and Insulin Resistance in Type 2 Diabetes
    Pfuetzner, A.
    Weber, M. M.
    Forst, T.
    DIABETES STOFFWECHSEL UND HERZ, 2008, 17 : S37 - S41
  • [48] Mechanisms of the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes (T2D)
    Muscelli, Elza
    Casolaro, Arturo
    Gastaldelli, Amalia
    Mari, Andrea
    Seghieri, Giuseppe
    Chen, Yu
    Alba, Maria
    Holst, Jens
    Ferrannini, Ele
    DIABETES, 2011, 60 : A267 - A267
  • [49] Interventions to Preserve Beta-Cell Function in the Management and Prevention of Type 2 Diabetes
    Page, Kathleen A.
    Reisman, Tamar
    CURRENT DIABETES REPORTS, 2013, 13 (02) : 252 - 260
  • [50] Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial
    van Ruiten, Charlotte C.
    Veltman, Dick J.
    Wijdeveld, Madelief
    Ten Kulve, Jennifer S.
    Kramer, Mark H. H.
    Nieuwdorp, Max
    IJzerman, Richard G.
    DIABETES OBESITY & METABOLISM, 2022, 24 (08): : 1588 - 1597
12345